Study on prognostic index for survival m-LCPI in patients with primary non-small cell lung cancer

Downloads

Download data is not yet available.
PDF (Tiếng Việt) Download: 38 View: 37

Indexing

CÁC SỐ TỪ 2011-2023
Tạp chí Y Dược Học

Abstract

Background: Lung cancer is a common cancer with a high mortality rate. The identification of prognostic factors in lung cancer patients in Vietnam is still limited and inconsistent in clinical practice. Objectives: To describe the clinical, paraclinical characteristics and m-LCPI index in patients with primary non-small cell lung cancer and evaluate the factors affecting overall survival in patients with primary non-small cell lung cancer. Methods: Prospective study of 210 cases of non-small cell lung cancer diagnosed with primary non-small cell lung cancer at the Oncology Department of Hue University of Medicine and Pharmacy Hospital and Hue Central Hospital from February 2020 to February 2023. Results: The majority of hospitalizations were at late stages, from stage IIIA (89%), group 3 and 4 in m-LCPI grading scale constituted the majority (80%). Average overall survival at 3 years was 20.0 ± 14 months, and gradually decreased to 54.8%, 40%, and 38.6% after 1 year, 2 years and 3 years, respectively. Regression analysis of COX model between m-LCPI and OS showed statistical significance with m-LCPI 4 (HR = 3.9, 95%CI = 1.57 - 9.69, p = 0.003), while m-LCPI 3 (HR = 2.44, 95% CI 0.97 - 6.13), p = 0.058) had a weak correlation. Conclusion: Our study shows that 38.6% of patients were still alive after 3 years of diagnosis. m-LCPI index is a good predictor of the patients’ overall survival.
https://doi.org/10.34071/jmp.2023.7.18
Published 2023-12-01
Fulltext
PDF (Tiếng Việt) Download: 38 View: 37
Language
Issue Vol. 13 No. 7 (2023)
Section Original Articles
DOI 10.34071/jmp.2023.7.18
Keywords non-small cell lung cancer, overall survival, prognostic index, mLCPI ung thư phổi không phải tế bào nhỏ, thời gian sống thêm toàn bộ, chỉ số tiên lượng m-LCPI

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Hue Journal of Medicine and Pharmacy

Hoang, T. M. T., Ha, X. T. A., Dang, V. K., Phan, M. T., Tran, T. X. T., Le, N. Q. H., Nguyen, T. H. M., & Tran, N. H. T. (2023). Study on prognostic index for survival m-LCPI in patients with primary non-small cell lung cancer. Hue Journal of Medicine and Pharmacy, 13(7), 133. https://doi.org/10.34071/jmp.2023.7.18